Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease (Q44316923)
Jump to navigation
Jump to search
scientific article published in February 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease |
scientific article published in February 2003 |
Statements
1 reference
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease (English)
1 reference
Hubert Scharnagl
1 reference
Wolfgang Koenig
1 reference
Nikolaus Marx
1 reference
Johannes Froehlich
1 reference
Laila Siam
1 reference
Jochen Ittner
1 reference
Gerhard Wierse
1 reference
Arnold Schmidt
1 reference
Vinzenz Hombach
1 reference
1 February 2003
1 reference
1 reference
23
1 reference
2
1 reference
283-288
1 reference
Identifiers
1 reference
1 reference